Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Blood
|
September 1, 1995
Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes
W J Murphy, S Funakoshi, M Beckwith, et al.
Blood
|
October 24, 1997
Antitumor effects of nonconjugated murine Lym-2 and human-mouse chimeric CLL-1 monoclonal antibodies against various human lymphoma cell lines in vitro and in vivo
S Funakoshi, A Hirano, M Beckwith, et al.
International Immunology
|
April 28, 2000
Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens
K Tani, W J Murphy, O Chertov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Role of daunorubicin in the induction therapy for adult acute myeloid leukemia
N Usui, N Dobashi, T Kobayashi, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Blood
|
September 1, 1995
Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes
W J Murphy, S Funakoshi, M Beckwith, et al.
Blood
|
October 24, 1997
Antitumor effects of nonconjugated murine Lym-2 and human-mouse chimeric CLL-1 monoclonal antibodies against various human lymphoma cell lines in vitro and in vivo
S Funakoshi, A Hirano, M Beckwith, et al.
International Immunology
|
April 28, 2000
Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens
K Tani, W J Murphy, O Chertov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Role of daunorubicin in the induction therapy for adult acute myeloid leukemia
N Usui, N Dobashi, T Kobayashi, et al.
Page
of 7